Climb Bio (CLYM) Shares Issued (2020 - 2026)
Climb Bio's (CLYM) quarterly Shares Issued came in at $8.5 million in Q1 2026, up 52.49% YoY from $5.6 million in Q1 2025, and up 31.95% on a QoQ basis from $6.4 million in Q4 2025.
Climb Bio (CLYM) Shares Issued (2020 - 2026) Analysis & Trends
Climb Bio (CLYM) has 7 years of Shares Issued data on file, last reported at $8.5 million in Q1 2026.
- Quarterly Shares Issued rose 52.49% year-over-year to $8.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.5 million (up 52.49% YoY) and the FY2025 annual result came in at $6.4 million, up 128.12% from the prior year.
- Shares Issued rose to $8.5 million in Q1 2026, from $6.4 million in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $8.5 million in Q1 2026 to a low of $971646.0 in Q3 2024.
- A 5-year average of $4.6 million and a median of $4.5 million in 2022 frame the typical range for Shares Issued.
- Annual changes were most pronounced in 2022 — Shares Issued jumped 2388.79% — and 2024, when it plunged 80.13%.
- Tracing CLYM's Shares Issued over 5 years: stood at $6.0 million in 2022, then declined by 23.41% to $4.6 million in 2023, then tumbled by 38.56% to $2.8 million in 2024, then soared by 128.12% to $6.4 million in 2025, then soared by 31.95% to $8.5 million in 2026.
- The last three Shares Issued figures came in at $8.5 million (Q1 2026), $6.4 million (Q4 2025), and $5.7 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Climb Bio | 1.24 Bn | 1.24 Bn | - | 8.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.47 Mn |
| Jun 30, 2026 | 8.47 Mn |
| Mar 31, 2026 | 8.48 Mn |
| Mar 31, 2026 | 8.48 Mn |
| Dec 31, 2025 | 6.43 Mn |
| Dec 31, 2025 | 6.43 Mn |
| Jun 30, 2025 | 5.66 Mn |
| Jun 30, 2025 | 5.66 Mn |
| Mar 31, 2025 | 5.56 Mn |
| Mar 31, 2025 | 5.56 Mn |
| Dec 31, 2024 | 2.82 Mn |
| Dec 31, 2024 | 2.82 Mn |
| Sep 30, 2024 | 971,646.00 |
| Sep 30, 2024 | 971,646.00 |
| Jun 30, 2024 | 1.55 Mn |
| Jun 30, 2024 | 1.55 Mn |
| Mar 31, 2024 | 4.26 Mn |
| Mar 31, 2024 | 4.26 Mn |
| Dec 31, 2023 | 4.59 Mn |
| Dec 31, 2023 | 4.59 Mn |